| 000 | 01715 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514201359.0 | ||
| 264 | 0 | _c20050214 | |
| 008 | 200502s 0 0 eng d | ||
| 022 | _a0893-133X | ||
| 024 | 7 |
_a10.1038/sj.npp.1300555 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSheline, Yvette I | |
| 245 | 0 | 0 |
_aDecreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography. _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cDec 2004 |
||
| 300 |
_a2235-41 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBrain Mapping |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aDepressive Disorder _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorine Radioisotopes _xpharmacokinetics |
| 650 | 0 | 4 |
_aHippocampus _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKetanserin _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 |
_aProtein Binding _xphysiology |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2A _xmetabolism |
| 700 | 1 | _aMintun, Mark A | |
| 700 | 1 | _aBarch, Deanna M | |
| 700 | 1 | _aWilkins, Consuelo | |
| 700 | 1 | _aSnyder, Abraham Z | |
| 700 | 1 | _aMoerlein, Stephen M | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 29 _gno. 12 _gp. 2235-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.npp.1300555 _zAvailable from publisher's website |
| 999 |
_c15062218 _d15062218 |
||